Do you suffer from uterine fibroids and have uterine bleeding?
Clinical Trial Seeking Participants
IRB 7812 (PI: Jeffrey Jensen, M.D., M.P.H.)
The Women's Health Research Unit is recruiting women for a clinical research study to determine the safety of the study drug, Elagolix, and how different doses of the drug work compared to placebo in reducing heavy uterine bleeding. To qualify, you should be pre-menopausal and age 20 or older.
Qualified participants will receive, at no cost:Study related physical and gynecologic exams, study medication, up to $900 in compensation for time and travel over the approximately nine month period of the study.
